Testing effectiveness (Phase 2)Looking for participantsNCT06762080
What this trial is testing
Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis
Who this might be right for
Leptomeningeal Metastasis
Guangzhou Medical University 36